Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
about
Prospective Clinical Testing of Regulatory Dendritic Cells in Organ TransplantationClinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative EffortRole of gut microbiota in the modulation of atherosclerosis-associated immune responseAntigen-based immunotherapy for autoimmune disease: current statusTargeting dendritic cell function during systemic autoimmunity to restore toleranceCellular Therapies in Systemic Sclerosis: Recent ProgressMinimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapiesEmerging drugs for immune thrombocytopenia (ITP).Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation.Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype.Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases.Unmet needs in autoimmunity and potential new tools.Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effectsVitamin D immunoregulation through dendritic cells.Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies.Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications.Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses.Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.The role of TGF-beta signaling in dendritic cell tolerance.Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4.Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis.Gene Therapy for Autoimmune Disease.Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis.Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules.Functionalization-dependent effects of cellulose nanofibrils on tolerogenic mechanisms of human dendritic cells
P2860
Q26767458-00164F21-3869-4930-8C22-1A11B3C98520Q26773299-262BEA48-04EE-4761-95D6-F0EBF7BC93DFQ26801649-0AE28240-722C-419C-9143-9929074EC5A6Q26852915-7A8DB669-27C5-4766-9509-2D67C84433FCQ27687098-C4A7E448-2279-4901-8488-F331F85DE592Q28080323-968DFF6A-7159-4C5F-881E-F744D7538477Q28596281-26D49174-AE26-4DCD-8F9F-4897D0B0A128Q33439789-3C879CAC-E9FA-4FAA-A425-E063802AB040Q35205506-42449EA8-AB8A-4EC9-AB66-75B9B4F9CBD7Q36104165-ECD6D2D7-7353-4364-B11C-5EF94C95A4D8Q36143414-CFEF354E-BCD6-4273-A9D1-487ABA832B06Q36854682-BB1D3D80-A41B-459B-9D7D-D0E3F1796E50Q36974852-8345ED32-2085-421F-A093-1BF265B497FFQ38193368-93D2B60C-9767-40B4-9607-1CCFB5C27A8EQ38218096-E25E67CB-8950-4B2B-9097-9CCF9AA2B0B7Q38797005-5D1E96BA-41CF-4930-91B0-9A122D72B0A5Q38847756-E47B0B60-CEA2-48E4-AD04-3AD2241E0BF4Q39085433-BE36DAA9-1DF2-4F7E-AE5E-54C09DC9BFF2Q39193752-F8ADAA61-EAAE-46E9-9DBF-E053CC7ED542Q40516749-8BA5EE6B-434A-490E-8C8F-9505A6AB9827Q48170058-B68BA0A8-329E-4961-9572-9BF28E714F10Q49376559-660C3912-F1B2-4D06-80B3-95E4FBF11FA6Q49906660-FF8779A7-A0B1-4DEE-A7C8-F711AF10CC1DQ51034724-BC809F4F-DD15-4D6D-BFCD-8BD9E79745DFQ53014578-6ECAE15B-C5FE-4442-8591-31249D02B1A8Q54211751-469F115B-3684-4EEF-BF1B-5EC3DBCD2A08Q55442040-B7BD3073-8965-41D2-BB00-1530438E7C41Q59125957-DB1D81B9-03AD-4FC9-9E2F-D5BC9ED9F87F
P2860
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tolerogenic dendritic cell vac ...... nable dream turn into reality?
@en
type
label
Tolerogenic dendritic cell vac ...... nable dream turn into reality?
@en
prefLabel
Tolerogenic dendritic cell vac ...... nable dream turn into reality?
@en
P2093
P1433
P1476
Tolerogenic dendritic cell vac ...... nable dream turn into reality?
@en
P2093
Amber H Nuyts
Ilse Van Brussel
Marthe Heylen
Miche Rombouts
Nathalie Cools
Wai Ping Lee
P304
P356
10.1016/J.AUTREV.2013.09.008
P577
2013-10-09T00:00:00Z